Companies › RVPH
Reviva Pharmaceuticals Holdings Inc (RVPH)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001742927 · EDGAR filings · Updated 2026-07-10
Reviva Pharmaceuticals Holdings Inc (RVPH) has reported institutional ownership of 22.8%, with 35 institutional managers holding positions valued at $2.13M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-10 — 25-NSE filed
- 2026-05-15 — SCHEDULE 13G/A filed
- 2026-05-14 — SCHEDULE 13G filed
- 2026-05-13 — Quarterly report (10-Q) filed
- 2026-05-13 — Current report (8-K) filed
- 2026-05-13 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Reviva Pharmaceuticals Holdings Inc has 35 institutional holders and institutional ownership of 22.8%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
Q/C TECHNOLOGIES INC (QCLS) · SYNERGY CHC CORP (SNYR) · VIVOS THERAPEUTICS INC (VVOS) · RADIOPHARM THERANOSTICS LTD (RADX) · PURETECH HEALTH PLC (PRTCY) · BIOFRONTERA INC (BFRI)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.